Acutus Medical Inc
OTC:AFIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Acutus Medical Inc
OTC:AFIB
|
US |
|
Windlas Biotech Ltd
NSE:WINDLAS
|
IN |
|
C
|
CCC SA
WSE:CCC
|
PL |
|
S
|
SillaJen Inc
KOSDAQ:215600
|
KR |
|
O
|
Osotspa PCL
SET:OSP
|
TH |
|
Aspial Corporation Ltd
SGX:A30
|
SG |
|
Cigna Corp
NYSE:CI
|
US |
|
E
|
Elron Ventures Ltd
TASE:ELRN
|
IL |
|
S
|
South Jersey Industries Inc
F:J4S
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AFIB's stock price target?
Not Available
AFIB doesn't have any price targets made by Wall Street professionals.
What is Acutus Medical Inc's Revenue forecast?
Projected CAGR
150%
For the last 5 years the
compound annual growth rate for
Acutus Medical Inc's revenue is
48%.
The projected
CAGR
for the next 1 year is
150%.